Wecare Study in Gastric Cancer Survivors
ConditionGastric Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-75
SponsorGyeongsang National University Hospital
About this trial
The KOrean QUality of life in Stomach cancer patients Study group (KOQUSS) made a method (KOQUSS-40) for assessing appropriately the quality of life of gastric cancer patients who have undergone gastrectomy, and developed a digital platform (Wecare) based on KOQUSS-40. In this study, we propose a randomized controlled trial to compare quality of life after gastrectomy in patients with and without smartphone app support.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patient (19-75 years) who underwent radical gastrectomy
Disqualifiers
Patients who were unable to undergo regular follow-up, lacked communication, or were deemed unsuitable to participate in this study by the researcher
Trial design
Design model
Parallel
Treatments tested in this trial
Wecare (website)
Other interventionsupport feedback of qutionaire \& supply educational contents
Treatment groups
88 Participants
are divided into 2 treatment groupsGroup A: conventional groupNo intervention 0 interventions
Group B: Wecare groupExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
the quality of life in gastric cancer survivor (KOQUSS-40)
KOQUSS-40 questionnaire has a 40-item questionnaire in 11 domains focusing on the symptoms evaluation after gastric cancer surgery.
Time frame
at 1, 3, and 6 months after surgery in the outpatient clinic.Secondary outcomes
1
Weight
Weight change
Time frame
at 1, 3, and 6 months after surgery in the outpatient clinic.2
nutritional index
nutritional index change
Time frame
at 1, 3, and 6 months after surgery in the outpatient clinic.3
KOQUSS-40 questionnaire compliance
check the KOQUSS-40 questionnaire compliance
Time frame
at 1, 3, and 6 months after surgery in the outpatient clinic.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Gyeongsang National University Hospital
Lead sponsor
National Cancer Center, Korea
Collaborator
Source ClinicalTrials.gov